Logo image of TAOP

TAOPING INC (TAOP) Stock Fundamental Analysis

NASDAQ:TAOP - Nasdaq - VGG8675V1278 - Common Stock - Currency: USD

0.3206  0 (-0.68%)

After market: 0.3175 0 (-0.97%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TAOP. TAOP was compared to 82 industry peers in the IT Services industry. Both the profitability and financial health of TAOP have multiple concerns. While showing a medium growth rate, TAOP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year TAOP was profitable.
TAOP had a negative operating cash flow in the past year.
TAOP had negative earnings in each of the past 5 years.
In the past 5 years TAOP always reported negative operating cash flow.
TAOP Yearly Net Income VS EBIT VS OCF VS FCFTAOP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M

1.2 Ratios

TAOP has a Return On Assets of 4.99%. This is in the better half of the industry: TAOP outperforms 62.82% of its industry peers.
TAOP's Return On Equity of 10.73% is fine compared to the rest of the industry. TAOP outperforms 65.38% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.43%, TAOP is in the better half of the industry, outperforming 60.26% of the companies in the same industry.
Industry RankSector Rank
ROA 4.99%
ROE 10.73%
ROIC 4.43%
ROA(3y)-15.81%
ROA(5y)-22.75%
ROE(3y)-43.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TAOP Yearly ROA, ROE, ROICTAOP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 -400

1.3 Margins

The Profit Margin of TAOP (3.99%) is comparable to the rest of the industry.
TAOP has a Operating Margin of 3.18%. This is comparable to the rest of the industry: TAOP outperforms 51.28% of its industry peers.
With a Gross Margin value of 21.39%, TAOP is not doing good in the industry: 75.64% of the companies in the same industry are doing better.
TAOP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.18%
PM (TTM) 3.99%
GM 21.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.28%
GM growth 5Y-13.42%
TAOP Yearly Profit, Operating, Gross MarginsTAOP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TAOP is destroying value.
TAOP has more shares outstanding than it did 1 year ago.
TAOP has more shares outstanding than it did 5 years ago.
TAOP has a worse debt/assets ratio than last year.
TAOP Yearly Shares OutstandingTAOP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M
TAOP Yearly Total Debt VS Total AssetsTAOP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

TAOP has an Altman-Z score of -6.28. This is a bad value and indicates that TAOP is not financially healthy and even has some risk of bankruptcy.
TAOP has a Altman-Z score of -6.28. This is amonst the worse of the industry: TAOP underperforms 92.31% of its industry peers.
A Debt/Equity ratio of 0.52 indicates that TAOP is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.52, TAOP is in line with its industry, outperforming 43.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z -6.28
ROIC/WACC0.53
WACC8.29%
TAOP Yearly LT Debt VS Equity VS FCFTAOP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

2.3 Liquidity

TAOP has a Current Ratio of 1.50. This is a normal value and indicates that TAOP is financially healthy and should not expect problems in meeting its short term obligations.
TAOP has a Current ratio of 1.50. This is comparable to the rest of the industry: TAOP outperforms 51.28% of its industry peers.
TAOP has a Quick Ratio of 1.33. This is a normal value and indicates that TAOP is financially healthy and should not expect problems in meeting its short term obligations.
TAOP has a Quick ratio of 1.33. This is in the lower half of the industry: TAOP underperforms 65.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.33
TAOP Yearly Current Assets VS Current LiabilitesTAOP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

4

3. Growth

3.1 Past

TAOP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 114.29%, which is quite impressive.
TAOP shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.49%.
TAOP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.40% yearly.
EPS 1Y (TTM)114.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.8%
Revenue 1Y (TTM)37.49%
Revenue growth 3Y51.55%
Revenue growth 5Y13.4%
Sales Q2Q%28.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TAOP Yearly Revenue VS EstimatesTAOP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
TAOP Yearly EPS VS EstimatesTAOP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.51 indicates a rather cheap valuation of TAOP.
Compared to the rest of the industry, the Price/Earnings ratio of TAOP indicates a rather cheap valuation: TAOP is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of TAOP to the average of the S&P500 Index (29.63), we can say TAOP is valued rather cheaply.
Industry RankSector Rank
PE 0.51
Fwd PE N/A
TAOP Price Earnings VS Forward Price EarningsTAOP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

TAOP's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. TAOP is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.95
TAOP Per share dataTAOP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

TAOP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TAOPING INC

NASDAQ:TAOP (2/21/2025, 8:00:01 PM)

After market: 0.3175 0 (-0.97%)

0.3206

0 (-0.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)09-07 2022-09-07/bmo
Earnings (Next)N/A N/A
Inst Owners4.47%
Inst Owner Change-10.81%
Ins Owners8.94%
Ins Owner ChangeN/A
Market Cap4.29M
Analysts82.86
Price TargetN/A
Short Float %1.7%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.51
Fwd PE N/A
P/S 0.1
P/FCF N/A
P/OCF N/A
P/B 0.27
P/tB 0.27
EV/EBITDA 0.95
EPS(TTM)0.63
EY196.51%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS3.19
BVpS1.18
TBVpS1.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.99%
ROE 10.73%
ROCE 8.55%
ROIC 4.43%
ROICexc 4.52%
ROICexgc 4.52%
OM 3.18%
PM (TTM) 3.99%
GM 21.39%
FCFM N/A
ROA(3y)-15.81%
ROA(5y)-22.75%
ROE(3y)-43.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.28%
GM growth 5Y-13.42%
F-Score5
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA 2.06
Cap/Depr 53.09%
Cap/Sales 3.34%
Interest Coverage 1.82
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.33
Altman-Z -6.28
F-Score5
WACC8.29%
ROIC/WACC0.53
Cap/Depr(3y)123.42%
Cap/Depr(5y)94.82%
Cap/Sales(3y)22.91%
Cap/Sales(5y)19.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)37.49%
Revenue growth 3Y51.55%
Revenue growth 5Y13.4%
Sales Q2Q%28.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y166.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.5%
OCF growth 3YN/A
OCF growth 5YN/A